Global (United States, European Union and China) Polypeptide Drug Market Research Report 2019-2025

Table of Contents

1 Polypeptide Drug Market Overview

• 1.1 Product Overview and Scope of Polypeptide Drug
• 1.2 Polypeptide Drug Segment by Type
  • 1.2.1 Global Polypeptide Drug Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Injection
  • 1.2.3 Nasal Administration
  • 1.2.4 Lung Administration
  • 1.2.5 Oral Administration
  • 1.2.6 Transdermal Administration
• 1.3 Polypeptide Drug Segment by Application
  • 1.3.1 Polypeptide Drug Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
  • 1.3.3 Digestive System Drugs (Gastrointestinal Type)
  • 1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
  • 1.3.5 Gynecologic or Obstetric Drug
  • 1.3.6 Tumor Drug
  • 1.3.7 Urinary System Drug
  • 1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
• 1.4 Global Polypeptide Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Polypeptide Drug Revenue 2015-2026
  • 1.4.2 Global Polypeptide Drug Sales 2015-2026
  • 1.4.3 Polypeptide Drug Market Size by Region: 2020 Versus 2026

2 Global Polypeptide Drug Market Competition by Manufacturers

• 2.1 Global Polypeptide Drug Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Polypeptide Drug Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Polypeptide Drug Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Polypeptide Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Polypeptide Drug Market Competitive Situation and Trends
  • 2.5.1 Polypeptide Drug Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Polypeptide Drug Players (Opinion Leaders)

3 Polypeptide Drug Retrospective Market Scenario by Region

• 3.1 Global Polypeptide Drug Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Polypeptide Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Polypeptide Drug Market Facts & Figures by Country
  • 3.3.1 North America Polypeptide Drug Sales by Country
  • 3.3.2 North America Polypeptide Drug Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Polypeptide Drug Market Facts & Figures by Country
  • 3.4.1 Europe Polypeptide Drug Sales by Country
  • 3.4.2 Europe Polypeptide Drug Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Polypeptide Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Polypeptide Drug Sales by Region
  • 3.5.2 Asia Pacific Polypeptide Drug Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Polypeptide Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Polypeptide Drug Sales by Country
  • 3.6.2 Latin America Polypeptide Drug Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Polypeptide Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Polypeptide Drug Sales by Country
  • 3.7.2 Middle East and Africa Polypeptide Drug Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Polypeptide Drug Historic Market Analysis by Type

• 4.1 Global Polypeptide Drug Sales Market Share by Type (2015-2020)
• 4.2 Global Polypeptide Drug Revenue Market Share by Type (2015-2020)
• 4.3 Global Polypeptide Drug Price Market Share by Type (2015-2020)
• 4.4 Global Polypeptide Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Polypeptide Drug Historic Market Analysis by Application

• 5.1 Global Polypeptide Drug Sales Market Share by Application (2015-2020)
• 5.2 Global Polypeptide Drug Revenue Market Share by Application (2015-2020)
• 5.3 Global Polypeptide Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Polypeptide Drug Business

• 6.1 Novartis
  • 6.1.1 Corporation Information
  • 6.1.2 Novartis Description, Business Overview and Total Revenue
  • 6.1.3 Novartis Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Novartis Products Offered
  • 6.1.5 Novartis Recent Development
• 6.2 Merck Serono
  • 6.2.1 Merck Serono Polypeptide Drug Production Sites and Area Served
  • 6.2.2 Merck Serono Description, Business Overview and Total Revenue
  • 6.2.3 Merck Serono Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Merck Serono Products Offered
  • 6.2.5 Merck Serono Recent Development
• 6.3 Ferring Pharmaceuticals
  • 6.3.1 Ferring Pharmaceuticals Polypeptide Drug Production Sites and Area Served
  • 6.3.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Ferring Pharmaceuticals Products Offered
  • 6.3.5 Ferring Pharmaceuticals Recent Development
• 6.4 Ipsen PHarma Biotech
  • 6.4.1 Ipsen PHarma Biotech Polypeptide Drug Production Sites and Area Served
  • 6.4.2 Ipsen PHarma Biotech Description, Business Overview and Total Revenue
  • 6.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Ipsen PHarma Biotech Products Offered
  • 6.4.5 Ipsen PHarma Biotech Recent Development
• 6.5 Lilly
  • 6.5.1 Lilly Polypeptide Drug Production Sites and Area Served
  • 6.5.2 Lilly Description, Business Overview and Total Revenue
  • 6.5.3 Lilly Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Lilly Products Offered
  • 6.5.5 Lilly Recent Development
• 6.6 Asahi Kasei
  • 6.6.1 Asahi Kasei Polypeptide Drug Production Sites and Area Served
  • 6.6.2 Asahi Kasei Description, Business Overview and Total Revenue
  • 6.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Asahi Kasei Products Offered
  • 6.6.5 Asahi Kasei Recent Development
• 6.7 AstraZeneca
  • 6.6.1 AstraZeneca Polypeptide Drug Production Sites and Area Served
  • 6.6.2 AstraZeneca Description, Business Overview and Total Revenue
  • 6.6.3 AstraZeneca Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 AstraZeneca Products Offered
  • 6.7.5 AstraZeneca Recent Development
• 6.8 SciClone Pharmaceuticals
  • 6.8.1 SciClone Pharmaceuticals Polypeptide Drug Production Sites and Area Served
  • 6.8.2 SciClone Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 SciClone Pharmaceuticals Products Offered
  • 6.8.5 SciClone Pharmaceuticals Recent Development
• 6.9 Takeda
  • 6.9.1 Takeda Polypeptide Drug Production Sites and Area Served
  • 6.9.2 Takeda Description, Business Overview and Total Revenue
  • 6.9.3 Takeda Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Takeda Products Offered
  • 6.9.5 Takeda Recent Development
• 6.10 Roche
  • 6.10.1 Roche Polypeptide Drug Production Sites and Area Served
  • 6.10.2 Roche Description, Business Overview and Total Revenue
  • 6.10.3 Roche Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Roche Products Offered
  • 6.10.5 Roche Recent Development
• 6.11 Sanofi
  • 6.11.1 Sanofi Polypeptide Drug Production Sites and Area Served
  • 6.11.2 Sanofi Polypeptide Drug Description, Business Overview and Total Revenue
  • 6.11.3 Sanofi Polypeptide Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Sanofi Products Offered
  • 6.11.5 Sanofi Recent Development

7 Polypeptide Drug Manufacturing Cost Analysis

• 7.1 Polypeptide Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Polypeptide Drug
• 7.4 Polypeptide Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Polypeptide Drug Distributors List
• 8.3 Polypeptide Drug Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Polypeptide Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Polypeptide Drug by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Polypeptide Drug by Type (2021-2026)
• 10.2 Polypeptide Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Polypeptide Drug by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Polypeptide Drug by Application (2021-2026)
• 10.3 Polypeptide Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Polypeptide Drug by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Polypeptide Drug by Region (2021-2026)
• 10.4 North America Polypeptide Drug Estimates and Projections (2021-2026)
• 10.5 Europe Polypeptide Drug Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Polypeptide Drug Estimates and Projections (2021-2026)
• 10.7 Latin America Polypeptide Drug Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Polypeptide Drug Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List